PROTOCOL FOR THE DESIGN AND INTERPRETATION OF METHOD EVALUATION IN ATOMIC-ABSORPTION SPECTROMETRIC ANALYSIS - APPLICATION TO THE DETERMINATION OF LEAD AND MANGANESE IN BLOOD

被引:30
作者
CHRISTENSEN, JM
POULSEN, OM
ANGLOV, T
机构
[1] Department of Chemistry and Biochemistry, Danish National Institute of Occupational Health, DK-2100 Copenhagen
关键词
METHOD EVALUATION; MANGANESE DETERMINATION; LEAD DETERMINATION; ELECTROTHERMAL ATOMIC ABSORPTION SPECTROMETRY; BLOOD;
D O I
10.1039/ja9920700329
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Results of measurements should be independent of the laboratory performing the analysis. Hence the laboratory should document that the method retains statistical control, is without systematic errors and has an acceptably low level of uncertainty. A protocol for the design and interpretation of method evaluation in atomic absorption spectrometry (AAS) using ordinary statistical calculations was applied to determinations of lead and manganese in blood by AAS. The method evaluation design provides information on whether or not the method is in statistical control, i.e., whether the values observed belong to a normal distribution around the mean values. The standard deviation of the normal distribution is an expression of the uncertainty of the method. Using the method evaluation design the estimated uncertainty is truly representative of the methods, i.e., both the within-run and between-run variations are included. Further, the method evaluation design produces estimates of the magnitude of the systematic error, the limit of detection and the limit of quantification. The application of the mean square error and the square root of the relative mean square error combines the systematic error with the total uncertainty. Hence the square root of the relative mean square error depicts the total analytical error. The systematic error, estimated as the magnitude of the zero point error and the proportional error of the method evaluation functions for Zeeman-effect AAS methods in the determination of manganese, were negligible. The blood lead method was unacceptable at concentrations higher than 200-mu-g dm-3 owing to the presence of a proportional error. The combined uncertainty of the analytical methods for manganese and lead were 1.00 and 11.1-mu-g dm-3, respectively, the limit of detection LOD(Mn) = 0.2-mu-g dm-3 and LOD(Pb) = 12-mu-g dm-3 at the concentration levels of 11-mu-g dm-3 of Mn and 72-mu-g dm-3 of Pb. The limit of quantification was LOQ(Mn) = 2.8-mu-g dm-3 and LOQ(Pb) = 33.7-mu-g dm-3. The design can be conveniently used for quality assurance in AAS analysis and for the characterization of analytical chemical methodology in general.
引用
收藏
页码:329 / 334
页数:6
相关论文
共 18 条
[1]   VALIDATION OF ASSAY METHODOLOGY USED IN PHARMACOKINETIC STUDIES [J].
AARONS, L ;
TOON, S ;
ROWLAND, M .
JOURNAL OF PHARMACOLOGICAL METHODS, 1987, 17 (04) :337-346
[2]   LYOPHILIZED HUMAN WHOLE-BLOOD FOR INTERNAL AND EXTERNAL QUALITY ASSURANCE OF LEAD IN BLOOD ASSAYS [J].
ANGLOV, T ;
CHRISTENSEN, JM ;
HOLST, E .
FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY, 1990, 338 (04) :530-533
[3]  
ANGLOV T, 1992, ANALYST, V117, P419
[4]  
ANGLOV T, UNPUB INT ARCH OCCUP
[5]  
ARMITAGE P, 1971, STATISTICAL METHODS
[6]   EVALUATION OF BLOOD LEAD LEVELS IN DANES FOR THE PERIOD 1976-1987 [J].
CHRISTENSEN, JM ;
HOLST, E .
FRESENIUS ZEITSCHRIFT FUR ANALYTISCHE CHEMIE, 1988, 332 (06) :710-713
[7]  
CHRISTENSEN JM, 1986, SCAND J CLIN LAB INV, V46, P170
[8]  
CHRISTENSEN JM, 1991, J ANAL CHEM-USSR, V371, P573
[9]  
HANSEN AM, 1991, ANN OCCUP HYG, V35, P603
[10]  
HOLST E, UNPUB J QUALITY TECH